New model estimates smoking's legal attribution to lung cancer cases

June 17, 2014 by William Raillant-Clark
New model estimates smoking's legal attribution to lung cancer cases

(Medical Xpress)—A newly developed model estimates smoking's attribution to lung cancer and finds that more than 90 percent of Quebec lung cancer cases can be legally attributed to smoking, according to a new study in the American Journal of Public Health published by Jack Siemiatycki of the University of Montreal's Institute for Public Health Research. Legal attribution incorporates the notion of "more likely than not" or equivalently that the probability of causation due to smoking was greater than 0.50.

The model is based on the dose-response relationship between and lung cancer, and the smoking pattern among . Researchers measured the extent of smoking through a pack-years measure, which integrates the amount smoked per day and the number of years that the person smoked. The model was developed in response to a request from lawyers of a in Quebec against the tobacco industry on behalf of patients with lung cancer that was allegedly caused by smoking.

The researchers estimated that the amount of smoking required to satisfy the legal criterion of "more likely than not" is between 3 and 12 pack-years, depending on the modelling assumptions. Based on smoking patterns among lung cancer cases in Quebec, they further estimated that more than 90 percent of the cases satisfied even the most conservative of these thresholds and could be legally attributed to smoking.

"In Quebec, where there were about 6,200 newly diagnosed cases of per year from 1995 to 2006, this translates to a total of about 5,700 cases per year that would satisfy the criterion of probability of causation greater than 0.50," the researchers explain.

Explore further: The scarier the better—screening results that make smokers stop smoking

More information: Jack Siemiatycki, Igor Karp, Marie-Pierre Sylvestre, and Javier Pintos.  (2014). "Estimating the Proportion of Cases of Lung Cancer Legally Attributable to Smoking: A Novel Approach for Class Actions Against the Tobacco Industry." American Journal of Public Health. e-View Ahead of Print. DOI: 10.2105/AJPH.2014.302040

Related Stories

The scarier the better—screening results that make smokers stop smoking

May 28, 2014
Screening for lung cancer leads to early detection and treatment, but can it also make people stop smoking before they get cancer? The answer is that it depends on the seriousness of the results, according to a study published ...

Annual lung cancer screening benefits outweigh risks for some

December 31, 2013
(Medical Xpress)—You may have heard in recent days about new guidelines on lung cancer screening put forth by the U.S. Preventative Services Task Force.

Improved diagnostic performance of low-dose computed tomography screening

June 16, 2014
Investigators of the COSMOS (Continuous Observation of SMOking Subjects) study show good compliance and patient survival outcomes using a 5-year low-dose computed tomography (LDCT) screening protocol in individuals at high-risk ...

S. Korea state insurer sues three tobacco makers

April 14, 2014
South Korea's state health insurer said Monday it had filed a lawsuit against three domestic and foreign tobacco makers, seeking damages of 53.7 billion won ($51.6 million) for payouts over smoking-related illnesses.

Analysis finds wide variation in lung cancer rates globally

May 16, 2014
The only recent comprehensive analysis of lung cancer rates for women around the world finds lung cancer rates are dropping in young women in many regions of the globe, pointing to the success of tobacco control efforts. ...

Rising tobacco epidemic in Asia linked to elevated risk of death

June 11, 2014
(Medical Xpress)—A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.